205 related articles for article (PubMed ID: 19880629)
1. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
Perla-Kaján J; Jakubowski H
FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase 1 and homocysteine metabolism.
Perła-Kaján J; Jakubowski H
Amino Acids; 2012 Oct; 43(4):1405-17. PubMed ID: 22643843
[TBL] [Abstract][Full Text] [Related]
3. N-Homocysteinylation impairs collagen cross-linking in cystathionine β-synthase-deficient mice: a novel mechanism of connective tissue abnormalities.
Perła-Kajan J; Utyro O; Rusek M; Malinowska A; Sitkiewicz E; Jakubowski H
FASEB J; 2016 Nov; 30(11):3810-3821. PubMed ID: 27530978
[TBL] [Abstract][Full Text] [Related]
4. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Jakubowski H
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
[TBL] [Abstract][Full Text] [Related]
5. Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans.
Jakubowski H; Boers GH; Strauss KA
FASEB J; 2008 Dec; 22(12):4071-6. PubMed ID: 18708589
[TBL] [Abstract][Full Text] [Related]
6. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
[TBL] [Abstract][Full Text] [Related]
7. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
Ferretti G; Bacchetti T; Marotti E; Curatola G
Metabolism; 2003 Feb; 52(2):146-51. PubMed ID: 12601623
[TBL] [Abstract][Full Text] [Related]
8. Paraoxonase 1 Q192R genotype and activity affect homocysteine thiolactone levels in humans.
Perła-Kaján J; Borowczyk K; Głowacki R; Nygård O; Jakubowski H
FASEB J; 2018 May; ():fj201800346R. PubMed ID: 29782204
[TBL] [Abstract][Full Text] [Related]
9. The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.
Jakubowski H
Adv Exp Med Biol; 2010; 660():113-27. PubMed ID: 20221875
[TBL] [Abstract][Full Text] [Related]
10. Modulation of paraoxonase 1 and protein N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the rat.
Beltowski J; Wójcicka G; Jakubowski H
J Endocrinol; 2010 Feb; 204(2):191-8. PubMed ID: 19887391
[TBL] [Abstract][Full Text] [Related]
11. Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis.
Jakubowski H; Ambrosius WT; Pratt JH
FEBS Lett; 2001 Feb; 491(1-2):35-9. PubMed ID: 11226414
[TBL] [Abstract][Full Text] [Related]
12. The correlation of homocysteine-thiolactonase activity of the paraoxonase (PON1) protein with coronary heart disease status.
Domagała TB; Łacinski M; Trzeciak WH; Mackness B; Mackness MI; Jakubowski H
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(5):4-10. PubMed ID: 17543199
[TBL] [Abstract][Full Text] [Related]
13. Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice.
Jakubowski H; Perla-Kaján J; Finnell RH; Cabrera RM; Wang H; Gupta S; Kruger WD; Kraus JP; Shih DM
FASEB J; 2009 Jun; 23(6):1721-7. PubMed ID: 19204075
[TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
[TBL] [Abstract][Full Text] [Related]
16. Serum paraoxonase 1 activity and protein N-homocysteinylation in primary human endometrial cancer.
Gałczyński K; Bełtowski J; Nowakowski Ł; Vasilevska D; Rechberger T; Semczuk A
Tumour Biol; 2018 Sep; 40(9):1010428318797869. PubMed ID: 30178714
[TBL] [Abstract][Full Text] [Related]
17. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice.
Chwatko G; Boers GH; Strauss KA; Shih DM; Jakubowski H
FASEB J; 2007 Jun; 21(8):1707-13. PubMed ID: 17327360
[TBL] [Abstract][Full Text] [Related]
18. [Mechanisms that protect against homocysteine toxicity].
Zimny J
Postepy Biochem; 2008; 54(1):91-8. PubMed ID: 18610586
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and neurotoxicity of homocysteine thiolactone in mice: protective role of bleomycin hydrolase.
Borowczyk K; Tisończyk J; Jakubowski H
Amino Acids; 2012 Sep; 43(3):1339-48. PubMed ID: 22227865
[TBL] [Abstract][Full Text] [Related]
20. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
